Health Centre Point is seeking patient with the following criteria to participate in a clinical trial. Please read the information below to find out if you are
eligible to participate in this clinical trial.
Trial registration number: ACTRN12614000836639
Registry name: ANZCTR
Universal Trial Number: U1111-1158-9653
HREC Approval Number: 2014-10-542
Protocol Version: 01_V06 FINAL
In Search of Type 2 Diabetes Mellitus Patients
Have you been diagnosed with Type 2 Diabetes Mellitus within the past 1 to 10 years?
For the past 6 months, have you been taking sulphonylurea-only medication to treat your diabetes such as:
1) Glibenclamide, also known as
2) Gliclazide, also known as
3) Glipizide, also known
4) Glimepiride, also known as
The Health Centre Point is seeking volunteer Type 2 diabetes patients to participate in a clinical study, that will investigate if an investigational drug
(OZ101), taken in combination with your sulphonylurea-only medication, results in better control of blood glucose and improves the treatment of type 2
If you are between 25 to 65 years of age and your condition has been stable for the past 3 months then you may be eligible to participate in this study.
For more information please contact (02) 8883 0800 OR (02) 8883 0811 OR firstname.lastname@example.org OR email@example.com.
For further information please also visit http://healthcentrepoint.com.au/.
OZ-14-101 Trial Advertisement (Version 3) 29 October 2015